Until recently, dry eye syndrome (DES) was often considered as a minor, relatively harmless condition. Today, it is recognized as a chronic inflammatory disease with complex causes that can significantly affect quality of life. The clinical approach has evolved, and so have the diagnostic tools which now enable more precise assessment and the selection of targeted, effective treatments. Let’s take a closer look at contemporary DES diagnostics to see which devices can support it. Discover how you can use Optopol equipment you already have to expand your diagnostic capabilities without a major investment.
From symptoms to answers
Symptoms of dry eye syndrome include a burning sensation, the feeling of grit under the eyelids, sensitivity to light, and, paradoxically, even excessive tearing. DES is among the most frequently reported eye conditions, affecting 30–50% of adults. Today, clinicians no longer rely solely on patients’ subjective reports. Standardized tools, such as the Ocular Surface Disease Index (OSDI), are now increasingly used to quantify symptom severity and monitor treatment effectiveness. Additionally, some of the already existing systems can be used in DES diagnostics as well.
Dry eye syndrome vs MGD – don’t confuse the cause
We now understand that up to 80% of DES cases are linked to dysfunction in the secretion of lipids by the Meibomian glands. As a result, modern diagnostics can no longer do without meibography, an imaging technique that visualizes gland structure and helps identify blockages, atrophies, or deformities. In the past, such changes often remained undetected, and patients were typically prescribed artificial tears, which only provided momentary relief. Today, there is a growing emphasis on tailoring treatment to the specific type of DES.
What tools can be used?
Although the REVO NX OCT is not specifically designed for DES diagnostics, it can assist in evaluating symptoms accompanying this condition. With EMR integration, it also enables thorough documentation and easy comparison of results over time. The REVO NX equipped with the OCT-Topography module enables analysis of the corneal surface, which is very useful when watery eyes, refractive errors, or eye dryness affect the quality of vision. All patient examination data is stored in a single database, simplifying future comparisons and disease progression monitoring. More and more clinics are taking the step to expand their capabilities with devices that analyze tear film stability, the tear meniscus, and Meibomian gland function. With EMR and DICOM compatibility, the REVO can integrate results from these devices into a single database to build a more complete picture of the patient’s condition within one single software platform. Comprehensive diagnostics are increasingly conducted as part of assessment of the anterior segment of the eye, especially before cataract surgery, refractive surgery, or in patients with coexisting corneal conditions. In practice, many doctors integrate the REVO system with analyzers from other manufacturers, with data shared through EMR software following appropriate configuration.
Benefits for patients and clinicians
Process automation supports measurements, analysis, and comparison of results. Accuracy is improved because examination results can be easily compared during subsequent visits, as the data is stored in a way that guarantees quick and convenient access. Patient education is enhanced through visualization of changes and before-and-after reports that help patients make the decision to undergo treatment.
Objective data means more effective treatment
The introduction of standardized measurements and modern diagnostic tools enables not only more accurate diagnosis but also effective treatment monitoring. Following the implementation of treatment, whether IPL therapy, anti-inflammatory measures, procedures to unblock the Meibomian glands, or modifications to pharmacotherapy, the doctor can objectively monitor the effects, including improvements in tear film stability, increases in meniscus volume, and changes in glandular structure. This approach is particularly valuable for patients who have long struggled to achieve noticeable improvement.
DES diagnostics in practice
For ophthalmologists and optometrists, this signals a shift in clinical approach. Modern DES diagnostics are far less time-consuming. Current technologies make the examination fast, taking only 5–10 minutes, objective through reports, photos, and data storage, and conducive to patient education thanks to visualization of changes and before-and-after results. Diagnostics can also be performed non-invasively, without the need for fluorescein, using tools such as tear film analyzers or the NIBUT test.
In a nutshell
If you already use Optopol devices in your practice, you are well equipped to perform DES diagnostics. It now comes down to proper application of the available modules and, if necessary, adding a single specialized component. Investing in entirely new equipment is not always required, as thoughtful integration is often sufficient.